Clearside Biomedical Inc (NASDAQ:CLSD) price on Friday, February 07, rose 5.61% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.13.
A look at the stock’s price movement, the close in the last trading session was $1.07, moving within a range at $1.06 and $1.14. The beta value (5-Year monthly) was 2.332. Turning to its 52-week performance, $2.12 and $0.80 were the 52-week high and 52-week low respectively. Overall, CLSD moved 14.72% over the past month.
Clearside Biomedical Inc’s market cap currently stands at around $85.70 million, with investors looking forward to this quarter’s earnings report slated for in March.
The average forecast suggests down to a -95.36% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 1.68M, representing a -79.62% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CLSD is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in Hold category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend CLSD as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CLSD’s current price about 17.67% and 15.06% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 72.38, while 7-day volatility ratio is 8.34% and 6.01% in the 30-day chart. Further, Clearside Biomedical Inc (CLSD) has a beta value of 2.09, and an average true range (ATR) of 0.06.
If we refocus on Clearside Biomedical Inc (NASDAQ:CLSD), historical trading data shows that trading volumes averaged 0.17 over the past 10 days and 251.13K over the past 3 months. The company’s latest data on shares outstanding shows there are 74.75 million shares.
The 15.29% of Clearside Biomedical Inc’s shares are in the hands of company insiders while institutional holders own 15.82% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.76 million on 2024-10-31, giving us a short ratio of 1.21. The data shows that as of 2024-10-31 short interest in Clearside Biomedical Inc (CLSD) stood at 250.0 of shares outstanding, with shares short rising to 0.26 million registered in 2024-09-30. Current price change has pushed the stock 18.95% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CLSD stock continues to rise going into the next quarter.
